||||||||||SHR2150 / Jiangsu Hengrui Pharma Enrollment closed: A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers (clinicaltrials.gov) - Dec 20, 2021 P1, N=20, Active, not recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd. Enrolling by invitation --> Completed Not yet recruiting --> Active, not recruiting
||||||||||SHR2150 / Jiangsu Hengrui Pharma Enrollment open, Trial completion date, Trial primary completion date: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ?Pharmacodynamics of Oral SHR2150 in Healthy Subjects (clinicaltrials.gov) - Oct 27, 2021 P1, N=50, Enrolling by invitation, Sponsor: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting --> Active, not recruiting Not yet recruiting --> Enrolling by invitation | Trial completion date: Jul 2021 --> Dec 2021 | Trial primary completion date: Jul 2021 --> Nov 2021